Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05809245 · ClinicalTrials.gov registry record · NA
Corneal Neurotization as a Treatment for Neurotrophic Keratopathy
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05809245: Clinical Trial NA study, sponsored by Stanford University.
NCT05809245 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05809245, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of sural nerve transfer and cadaveric nerve graft to re-establish corneal sensation in patients with neurotrophic keratopathy.
Interventions
- PROCEDURE Corneal neurotization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-03-15 |
| Est. Completion | 2020-02-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05809245
The ClinicalTrials.gov registry entry for NCT05809245 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corneal neurotization is the first listed.
NCT05809245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05809245 about?
NCT05809245 is a clinical study titled "Corneal Neurotization as a Treatment for Neurotrophic Keratopathy". The purpose of this study is to assess the efficacy of sural nerve transfer and cadaveric nerve graft to re-establish corneal sensation in patients with neurotrophic keratopathy.
What is the current status of trial NCT05809245?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-03-15. Estimated completion is 2020-02-12.
What interventions are being tested in trial NCT05809245?
The interventions under investigation include: Corneal neurotization (PROCEDURE).
Who is sponsoring clinical trial NCT05809245?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.